TITLE
ERalpha-negative ERbeta-positive breast carcinoma response to tamoxifen

SUMMARY
Analysis of estrogen receptor (ER) alpha negative ERbeta-positive breast cancer tumors from patients treated with tamoxifen for 2 years. Unlike ERalpha-negative ERbeta-negative breast cancers, ERalpha-negative ERbeta-positive cancers respond favorably to tamoxifen treatment.

ORGANISM
Homo sapiens

